What is the appropriate management for a patient with an arterial carbon dioxide (CO₂) level of 35 mmol/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of CO₂ Level of 35 mmHg

A CO₂ level of 35 mmHg (4.7 kPa) is within the normal range and requires no specific intervention unless the patient has clinical signs of respiratory distress or underlying conditions predisposing to hypercapnic respiratory failure.

Understanding the Context

The normal arterial CO₂ range is 34-46 mmHg (4.6-6.1 kPa) 1. A value of 35 mmHg sits at the lower end of normal, technically representing mild hypocapnia but not clinically significant in isolation.

Clinical Assessment Algorithm

Step 1: Assess pH and Clinical Context

  • Check arterial pH: If pH is normal (7.35-7.45), this CO₂ level represents normal ventilation 1
  • Evaluate for respiratory alkalosis: If pH >7.45 with CO₂ of 35 mmHg, consider causes of hyperventilation (anxiety, pain, metabolic compensation)
  • Look for underlying conditions: COPD, neuromuscular disease, obesity hypoventilation, or chest wall disorders that may predispose to CO₂ retention 1

Step 2: Oxygen Saturation Targets Based on Risk Profile

For patients WITHOUT risk of hypercapnic respiratory failure:

  • Target SpO₂: 94-98% 1
  • This includes most acute conditions (pneumonia, asthma, pulmonary embolism, acute coronary syndrome)

For patients WITH risk of hypercapnic respiratory failure:

  • Target SpO₂: 88-92% 1
  • Risk factors include: severe/moderate COPD, cystic fibrosis, severe chest wall/spinal disease, neuromuscular disease, severe obesity, bronchiectasis 1
  • Recheck blood gases at 30-60 minutes to monitor for rising CO₂ or falling pH 1

Step 3: Oxygen Delivery Method (if hypoxemic)

Initial oxygen therapy:

  • Nasal cannulae at 2-6 L/min OR simple face mask at 5-10 L/min 1
  • If SpO₂ <85%: Use reservoir mask at 15 L/min 1
  • For at-risk patients: Use 24% Venturi mask at 2-3 L/min or 28% Venturi mask at 4 L/min 1

Critical Pitfalls to Avoid

1. Excessive Oxygen in At-Risk Patients

Avoid excessive oxygen use in patients with COPD or other conditions predisposing to hypercapnic respiratory failure 1. The risk of respiratory acidosis increases if PaO₂ rises above 10.0 kPa (75 mmHg) due to excessive oxygen 1.

2. Sudden Oxygen Cessation

If a patient develops hypercapnia from excessive oxygen, never abruptly stop oxygen therapy - this causes life-threatening rebound hypoxemia with rapid desaturation below baseline 1. Instead, step down gradually to maintain SpO₂ 88-92% using 24-28% Venturi mask or 1-2 L/min nasal cannulae 1.

3. Oxygen Without Monitoring in Neuromuscular Disease

In patients with Duchenne muscular dystrophy or other neuromuscular conditions, oxygen therapy alone without ventilatory support is relatively contraindicated as even low-flow oxygen can worsen hypercapnia 2. Hypoxemia (SpO₂ <95%) should prompt assessment for need of non-invasive ventilation 2.

When to Escalate Care

Initiate NIV if:

  • CO₂ rises to >45 mmHg (6 kPa) with pH <7.35 and respiratory acidosis persists >30 minutes after standard medical management 1, 3
  • Patient shows signs of respiratory distress with hypercapnia 4, 5
  • Hypoxemia cannot be corrected with controlled oxygen therapy 4

Consider ICU/CCU admission for:

  • Persistent significant dyspnea or hemodynamic instability 4
  • Recurrent arrhythmias or associated acute coronary syndrome 4
  • Need for intubation or already intubated 4

Special Populations

COPD patients: If CO₂ is normal but bicarbonate >28 mmol/L, suspect chronic compensated hypercapnia - maintain target SpO₂ 88-92% and recheck gases in 30-60 minutes 1

Acute heart failure: Consider CPAP or NIV for pulmonary edema; monitor blood pressure as non-invasive positive pressure can reduce BP 4

Post-cardiac arrest: Current evidence shows no benefit of targeting mild hypercapnia (50-55 mmHg) over normocapnia (35-45 mmHg) for neurologic outcomes 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.